Cargando…

Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

Anti-spike monoclonal antibody therapy may be effective for pregnant women with coronavirus disease 2019 (COVID-19).

Detalles Bibliográficos
Autores principales: Thilagar, Bright P., Ghosh, Aditya K., Nguyen, Jerome, Theiler, Regan N., Wick, Myra J., Hurt, Ryan T., Razonable, Raymund R., Ganesh, Ravindra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936149/
https://www.ncbi.nlm.nih.gov/pubmed/35026789
http://dx.doi.org/10.1097/AOG.0000000000004700
_version_ 1784672163462119424
author Thilagar, Bright P.
Ghosh, Aditya K.
Nguyen, Jerome
Theiler, Regan N.
Wick, Myra J.
Hurt, Ryan T.
Razonable, Raymund R.
Ganesh, Ravindra
author_facet Thilagar, Bright P.
Ghosh, Aditya K.
Nguyen, Jerome
Theiler, Regan N.
Wick, Myra J.
Hurt, Ryan T.
Razonable, Raymund R.
Ganesh, Ravindra
author_sort Thilagar, Bright P.
collection PubMed
description Anti-spike monoclonal antibody therapy may be effective for pregnant women with coronavirus disease 2019 (COVID-19).
format Online
Article
Text
id pubmed-8936149
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-89361492022-04-01 Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19) Thilagar, Bright P. Ghosh, Aditya K. Nguyen, Jerome Theiler, Regan N. Wick, Myra J. Hurt, Ryan T. Razonable, Raymund R. Ganesh, Ravindra Obstet Gynecol Contents Anti-spike monoclonal antibody therapy may be effective for pregnant women with coronavirus disease 2019 (COVID-19). Lippincott Williams & Wilkins 2022-04 2022-01-13 /pmc/articles/PMC8936149/ /pubmed/35026789 http://dx.doi.org/10.1097/AOG.0000000000004700 Text en © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Contents
Thilagar, Bright P.
Ghosh, Aditya K.
Nguyen, Jerome
Theiler, Regan N.
Wick, Myra J.
Hurt, Ryan T.
Razonable, Raymund R.
Ganesh, Ravindra
Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
title Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
title_full Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
title_fullStr Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
title_full_unstemmed Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
title_short Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
title_sort anti-spike monoclonal antibody therapy in pregnant women with mild-to-moderate coronavirus disease 2019 (covid-19)
topic Contents
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936149/
https://www.ncbi.nlm.nih.gov/pubmed/35026789
http://dx.doi.org/10.1097/AOG.0000000000004700
work_keys_str_mv AT thilagarbrightp antispikemonoclonalantibodytherapyinpregnantwomenwithmildtomoderatecoronavirusdisease2019covid19
AT ghoshadityak antispikemonoclonalantibodytherapyinpregnantwomenwithmildtomoderatecoronavirusdisease2019covid19
AT nguyenjerome antispikemonoclonalantibodytherapyinpregnantwomenwithmildtomoderatecoronavirusdisease2019covid19
AT theilerregann antispikemonoclonalantibodytherapyinpregnantwomenwithmildtomoderatecoronavirusdisease2019covid19
AT wickmyraj antispikemonoclonalantibodytherapyinpregnantwomenwithmildtomoderatecoronavirusdisease2019covid19
AT hurtryant antispikemonoclonalantibodytherapyinpregnantwomenwithmildtomoderatecoronavirusdisease2019covid19
AT razonableraymundr antispikemonoclonalantibodytherapyinpregnantwomenwithmildtomoderatecoronavirusdisease2019covid19
AT ganeshravindra antispikemonoclonalantibodytherapyinpregnantwomenwithmildtomoderatecoronavirusdisease2019covid19